Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Understanding Same Day Options
Arianne Adams, Head of Derivatives and Global Client Services at CBOE, joins Cheddar News to break down what exactly same day options are, how they are traded, the benefits of same day options, and so much more.
Load More